US & European Coenzyme Q10 Market to Exceed $133.3 Million by 2015, According to New Report by Global Industry Analysts, Inc.

Share Article

GIA announces the release of a comprehensive US & European market report on Coenzyme Q10. The US & European market for Coenzyme Q10 is projected to exceed $133.3 million by the year 2015. This is primarily driven by surging importance of CoQ10 in food and beverage processing industries and emerging role of the Coenzyme in heart health, cognitive health and anti-ageing sectors.

Coenzyme Q10: A US & European Market Report

With increased expansions into newer product segments and market spaces, the Coenzyme Q10 (CoQ10) industry is expected to witness a global rise. The GRAS status and enhanced availability, along with growing market for non-caffeinated energy fortifies the position of CoQ10 in the food and beverage processing industries. The emerging role of the Coenzyme in heart health, cognitive health and anti-ageing, led to the immense popularity of CoQ10. The emerging field of brain health, in addition to the significant number of large-scale clinical trials for proving the effect of CoQ10 in delaying Parkinson’s disease, has led to substantial growth of CoQ10 market.

The United States represents a major market for Coenzyme Q10 as stated by the new market research report on Coenzyme Q10 market. Health benefits provided by CoQ10 supplementation, low and stabilized prices, high recommendation from doctors as specialty supplement, and its usefulness in controlling various diseases such as heart health, gingivitis and Parkinson's disease are driving the CoQ10 market growth in the US. Besides being used for energy and cardiac benefits, CoQ10 is also gaining market for its usage in obesity, fertility and eye care. The product is increasingly being used in food and beverages, as well as in personal care products.

Europe represents the other principal market for Coenzyme Q10. With the discovery of new health benefits of CoQ10, the European manufacturers and marketers, who had already capitalized on the coenzyme’s proven cardiac benefits, witnessed significant enhancements. Market players are increasingly emphasizing on the newly discovered benefits of the coenzyme, particularly in healthy vision, infertility treatments, cellular energy production and migraine relief.

Major regional and global players profiled in the report include DSM Nutritional Products, Gnosis SpA, Kyowa Hakko U.S.A. Inc., Mitsubishi Gas Chemical America Inc., ZMC-USA LLC, Hwail Pharmaceutical Co. Ltd., Kaneka Corporation, PharmaEssentia Corporation, Mitsubishi Gas Chemical Company, and Nisshin Seifun Group Inc.

The report titled “Coenzyme Q10: A US & European Market Report” announced by Global Industry Analysts, Inc. provides a comprehensive review of market trends, product overview, product introductions, and recent industry activity. The study analyzes market data and analytics in terms of volume and value sales for regions including The United States and Europe.

For more details about this comprehensive market research report, please visit – http://www.strategyr.com/Coenzyme_Q10_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world’s largest market research publishers. The company employs over 800 people worldwide and publishes more than 1100 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Web Site http://www.StrategyR.com/

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website

Media